The dynamin family of GTPases has been implicated as novel regulators of the acrosome reaction, a unique exocytotic event that is essential for fertilization. Dynamin activity during the acrosome reaction is accompanied by phosphorylation of key serine residues. We now tested the hypothesis that glycogen synthase kinase 3 (GSK3) is the protein kinase responsible for dynamin phosphorylation at these phosphosites in mouse spermatozoa. Pharmacologic inhibition of GSK3 in mature mouse spermatozoa (CHIR99021: IC 50 = 6.7 nM) led to a significant reduction in dynamin phosphorylation (10.3% vs. 27.3%; P < 0.001), acrosomal exocytosis (9.7% vs. 25.7%; P < 0.01), and in vitro fertilization (53% vs. 100%; P < 0.01). GSK3 was shown to be present in developing germ cells where it colocalized with dynamin in the peri-acrosomal domain. However, additional GSK3 was acquired by maturing mouse spermatozoa within the male reproductive tract, via a novel mechanism involving direct interaction of sperm heads with extracellular structures known as epididymal dense bodies. These data reveal a novel mode for the cellular acquisition of a protein kinase and identify a key role for GSK3 in the regulation of sperm maturation and acrosomal
THE ACROSOME REACTION IS A unique exocytotic event that mammalian spermatozoa undergo to successfully fertilize the oocyte. During the final phases of the acrosome reaction, a number of focal fusions occur between the outer acrosomal membrane and the overlying plasma membrane of the sperm head. These fusions are the result of interactions between complementary soluble Nethylmaleimide-sensitive factor activating protein receptors on the plasma and outer acrosomal membranes (1) . However, soluble N-ethylmaleimide-sensitive factor activating protein receptor proteins are unlikely to be the sole regulators of acrosomal membrane fusion events, which occur at a much slower rate than the rapid membrane fusions typically associated with comparable exocytotic events in other cell types, including synapses (2, 3) . Studies from our laboratory have identified a key role for members of the dynamin family of large GTPases during the acrosome reaction (4) . Dynamin is well established as a master controller of membrane fission during endocytotic events as diverse as homotypic membrane fusion and viral infection (e.g., internalization of the Ebola virus) (5) . However, it has also recently become apparent that dynamin can promote exocytosis by virtue of its ability to lower the energy required for a hemifusion state during both membrane fission and fusion events (6, 7) .
The neural-enriched isoform, dynamin I, is present in mouse spermatozoa and becomes phosphorylated on Ser-774 and Ser-778 (Ser-778 is orthologous to Ser-764 of dynamin II, whereas Ser-774 is missing in this isoform) on treatment of spermatozoa with progesterone to induce acrosomal exocytosis (4) . These phosphorylation events were proposed to stabilize membrane fusion pores by reducing the GTPase activity of dynamin, thus prolonging the exocytotic event (7) . To achieve a better understanding of the mechanisms involved in the acrosome reaction, we sought to identify whether the protein kinases responsible for dynamin phosphorylation in neuronal cells also play a conserved role in mouse spermatozoa. Dynamin I phosphorylation in neurons and chromaffin cells occurs in a sequential manner with the phosphorylation of Ser-778 preceding that of Ser-774. Phosphorylation of Ser-774 is known to be the primary functional site for controlling activity-dependent bulk endocytosis of synaptic vesicles (8) . In neuronal cells, phosphorylation of dynamin I Ser-778 is mediated by cyclin-dependent kinase 5 (CDK5). This is a priming phosphosite that allows glycogen synthase kinase 3 (GSK3) to subsequently phosphorylate Ser-774 (8) .
Although CDK5 is also present in spermatozoa, its localization is restricted to the tail of developing germ cells (9) , a position that is at odds with a putative role in dynamin phosphorylation and the regulation of acrosomal exocytosis in the head. GSK3 is also present in the spermatozoa of diverse species in addition to the testes of the mouse (10) (11) (12) (13) (14) (15) . In mature spermatozoa, GSK3 has been implicated in the regulation of motility (14, 16, 17) , and its activity has been used as a marker for the regulation of glycogen synthesis (18) . However, these studies have largely focused on auto-phosphorylation of the kinase itself rather than identification of its possible downstream targets. There are few reported functional links between GSK3 activity and acrosomal status; moreover, these studies have relied on the calcium ionophore A23187 to induce nonphysiological acrosome reactions (14) .
Because CDK5 and GSK3 are the known dynamin I kinases in neuronal and chromaffin cells, we hypothesized that these enzymes would also target dynamin during the progesterone-induced acrosome reaction in mouse spermatozoa. We used 3 approaches to test this hypothesis. The first featured a combination of immunoblotting and immunofluorescence assays to determine the presence and localization of CDK5 and GSK3 in mouse spermatozoa. Second, we used a proximity ligation assay (PLA) to examine the potential for interaction between such kinases and dynamin. Finally, specific pharmacological inhibitors of both kinases were used to investigate their role in dynamin phosphorylation and the progesteroneinduced acrosome reaction.
MATERIALS AND METHODS

Animals
All experimental procedures were conducted with the approval of the University of Newcastle's Animal Care and Ethics Committee. Mice were housed under a controlled-lighting regime (16-hour light:8-hour dark) at 21-22°C and supplied with food and water ad libitum. Prior to dissection, animals were killed via CO 2 inhalation.
Antibodies and reagents
Unless otherwise stated, chemicals were purchased from SigmaAldrich (St. Louis, MO, USA) and were of molecular biology or research grade. Mouse monoclonal anti-GSK3 (05-412) antibody was purchased from Millipore (Billerica, MA, USA). Sheep polyclonal Ser-774 phosphorylated dynamin I (dynI p774) antibodies were generated in our laboratory against the synthetic phosphopeptide PAGRRS*PTSC (where the S* represents phospho-Ser) (19) . Goat polyclonal antibodies against heat shock 60 kDa protein 1 (HSPD1) (N-20) and acrosin binding protein (OY-TES-1; ACRBP), rabbit polyclonal antibodies against CDK5, bactericidal/permeability-increasing protein (BPI) (H130), and HSPD1 (H300), and anti-mouse IgG-horseradish peroxidase were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-rabbit IgG-horseradish peroxidase was from Millipore. Alexa Fluor 488-conjugated goat anti-rabbit and goat anti-mouse IgG, as well as Alexa Fluor 594 goat anti-rabbit, were from Life Technologies (Carlsbad, CA, USA). Anti-sheep IgG-FITC was from Santa Cruz Biotechnology. Yoyo-1, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, penicillin, and streptomycin were from Life Technologies. Bovine serum albumin was from Research Organics (Cleveland, OH, USA). Minicomplete protease inhibitor cocktail tablets were from Roche (Sandhoferstrasse, Mannheim, Germany). Nitrocellulose was from GE Healthcare (Buckinghamshire, England, United Kingdom). Mowiol 4-88 was from Millipore, and paraformaldehyde was from ProSciTech (Thuringowa, QLD, Australia). The synthetic GSK3 immunizing peptide (CKQLLHGEPNVSYICSRY) was purchased from Life Research (Scoresby, VIC, Australia). GSK3 inhibitors were from Reagents Direct (Encinitas, CA, USA) (CHIR99021) or Tocris Bioscience (Bristol, England, United kingdom) (A1070722 and TWS-119). The dynamin inhibitor, Dyngo-4a was generated in our laboratory as previously described (20, 21) . Dyngo is a trademark of Newcastle Innovation Ltd. and Children's Medical Research Institute and is available from Abcam (Cambridge, United Kingdom).
Preparation of spermatozoa
Capacitated and noncapacitated spermatozoa were prepared following collection from the cauda epididymides of adult male mice (.8 weeks old) as previously described (4) . Capacitation, as defined by hyperactivation, zona binding, and the ability to acrosome react, has been previously shown under these conditions (4, 22, 23) . Following collection, sperm vitality was assessed via the use of an eosin exclusion assay, and the percentage of sperm displaying forward progressive motility was determined. In all instances, a minimum of 100 spermatozoa were assessed, and .80% of this population were viable and progressively motile. These parameters were not adversely affected by any of the treatments reported in this study. The noncapacitated samples were used immediately, whereas the capacitated spermatozoa were prepared as previously described (4) . Caput and corpus spermatozoa were also isolated, assessed for their viability, and prepared as previously described (4, 24) .
SDS-PAGE and Western blotting
Proteins were extracted from spermatozoa and homogenized testis tissue (positive control) using SDS extraction buffer (0.375 M Tris, pH 6.8, 2% (w/v) SDS, 10% (w/v) sucrose, protease inhibitor cocktail) via incubation at 100°C for 5 minutes. The protein extracts were centrifuged at 17,000 g for 10 minutes at 4°C to remove insoluble material, and soluble proteins were quantified (BCA protein assay kit; Thermo Scientific, Scoresby, VIC, Australia). Proteins were resolved by SDS-PAGE and transferred onto nitrocellulose membranes. Membranes were blocked with 3% (w/v) nonfat dry milk powder in Tris-buffered saline (pH 7.4) for 1 hour before being probed with primary antibody (1:1500, anti-GSK3; 1:1000, anti-CDK5) in Tris-buffered saline containing 1% (w/v) milk powder and 0.1% (v/v) Tween-20 overnight at 4°C. Blots were washed 3 times in Tris-buffered saline with 0.1% (v/v) Tween-20, followed by incubation with appropriate horseradish peroxidase-conjugated secondary antibodies [diluted 1:5000, anti-GSK3; or 1:1000, anti-CDK5 in Tris-buffered saline with 0.1% (v/v) Tween-20] for 1.5 hours. Proteins were detected using an enhanced chemiluminescence kit (GE Healthcare). The relative levels of GSK3 expression in developing spermatozoa were assessed by densitometric analysis of Western blots using a-tubulin as a loading control (Image J; U.S. National Institutes of Health, Bethesda, MD, USA) (25) . The specificity of GSK3 antibody labeling was assessed by preabsorption of the primary antibody with a 400-fold molar excess of immunizing peptide at 4°C for 2 hours before overnight incubation with the membrane. Additionally, the specificity of phospho-dynamin antibodies was confirmed by treatment of sperm lysates with Antarctic phosphatase (New England Biolabs, Ipswich, MA, USA) in accordance with the manufacturers' recommendations.
Immunofluorescent localization
Mouse epididymal tissue was paraformaldehyde fixed, embedded in paraffin, and sectioned. Embedded tissue was dewaxed, rehydrated, and subjected to antigen retrieval by microwaving (3 3 3 minutes) in 10 mM sodium citrate (4). All subsequent incubations were performed at 37°C in a humid chamber, and all antibody dilutions and washes were conducted in PBS containing 0.1% Tween-20. Sections were blocked using 10% (v/v) goat serum supplemented with 3% (w/v) bovine serum albumin in PBS containing 0.1% Tween-20 for 1 hour. Slides were rinsed and incubated with anti-GSK3 (1:50) overnight at 4°C. Slides were washed 3 times, followed by incubation in appropriate Alexa Fluor 488-conjugated secondary (1:200) for 1 hour at room temperature. Sections were then washed and counterstained with propidium iodide (2 mg/ml) before being mounted in antifade reagent (13% Mowiol4-88, 33% glycerol, 66 mM Tris, pH 8.5, 2.5% 1,4-diazabicyclo-[2.2.2]octane) and viewed by confocal microscopy (Carl Zeiss, Sydney, NSW, Australia). For dual immunofluorescent staining of dense bodies, slides were stained as above with anti-GSK3 and either anti-HSPD1 (N-20) or anti-BPI overnight. The sections were then sequentially labeled with anti-mouse Alexa Fluor 488 and the appropriate Alexa Fluor 594-conjugated secondary antibodies for 1 hour at room temperature, and then mounted and viewed by confocal microscopy.
For immunofluorescent labeling of spermatozoa, cells were fixed and air-dried onto slides (4) before being subjected to antigen retrieval by heating at 90°C for 10 minutes in 100 mM Tris (pH 9.5) and 5% (w/v) urea. All subsequent incubations were performed in a humid chamber, and all antibody dilutions and washes were conducted in PBS. Cells were blocked, washed, and incubated in both primary and secondary antibodies as described for tissues. After washing, cells were counterstained for 20 minutes with fluorescently labeled peanut agglutinin (PNA; 1 mg/ml), a marker of the outer acrosomal membrane (26) . Mounting and viewing was performed as per tissue protocol. Preabsorbed antibody controls were included in both tissue and spermatozoa immunofluorescent localization studies.
Electron microscopy
Mouse epididymal tissue was dissected and fixed for electron microscopy in 4% (w/v) paraformaldehyde containing 0.5% (v/v) glutaraldehyde as previously described (27) . Sections were stained with 1% (v/v) OsO 4 before dehydration, infiltration, and embedding in LR White resin. Epididymal sections (100 nm) were cut with a diamond knife (Diatome Ltd., Bienne, Switzerland) on an Ultracut S microtome (Reichert-Jung, Leica; Solms, Germany) and placed on nickel grids. Subsequent washes were performed in Dulbecco's PBS (pH 7.4). Primary antibody (anti-GSK3) was diluted 1:20 and incubated at 4°C overnight. Secondary antibody conjugated to 5 nm gold particles was diluted 1:10 and incubated on grids for 2 hours at 37°C. Sections were counterstained in 1% (w/v) uranyl acetate in 40% (v/v) methanol. Micrographs were captured on a Jeol-100CX transmission electron microscope (Jeol, Tokyo, Japan) at 80 kV.
Acrosome reaction assays/phospho-dynamin labeling
Mouse spermatozoa were induced to acrosome react via progesterone stimulus following treatment with highly specific cellpermeable inhibitors as previously described (4) . The GSK3 specific inhibitors selected for inclusion in this study were CHIR99021, A1070722, and TWS-119 (28-31). Dyngo-4a (100 mM) was also used as a positive control because of its previously documented action in reducing progesterone-induced acrosomal exocytosis (4). Following incubation under appropriate conditions (noncapacitated, capacitated, DMSO vehicle, and kinase inhibited), spermatozoa were induced to acrosome react by treatment with 15 mM progesterone for 15 minutes. Sperm suspensions were then washed, resuspended in hypoosmotic swelling medium, and incubated for an additional 1 hour to detect viable cells (32) . Spermatozoa were then fixed and permeabilized by immersion in ice cold methanol for 10 minutes before being air-dried and prepared for fluorescent labeling as described above. The slides were stained with TRITC-labeled PNA (1 mg/ml) for 20 minutes at room temperature and mounted with 5 ml of antifade reagent, and the acrosomal status of viable cells was examined using a fluorescence microscope (Carl Zeiss). Immunofluorescent localization of dynamin I p774 was performed for each treatment group (2), and a minimum of 150 acrosome intact cells were categorized as either exhibiting positive or negative phospho-labeling. These analyses were underpinned by quantitative assessment of pixel intensity (Image J) (25) within the periacrosomal domain, whereby those cells displaying relative pixel intensities $2-fold than that observed in a control population of noncapacitated spermatozoa were recorded as positive (Supplemental Fig. S1 ).
Duolink PLAs
Duolink in situ proximity ligation was carried out per the manufacturer's instructions (Olink Biosciences, Uppsala, Sweden). Briefly, noncapacitated, capacitated, and progesterone-treated spermatozoa were prepared on slides as for immunofluorescence followed by incubation for 1 hour in blocking solution at 37°C. Sperm were then incubated with pairs of appropriate antibodies raised in different species (anti-GSK3: anti-dynI), as well as negative controls [anti-GSK3: anti-ACRBP, anti-GSK3: anti-HSPD1 (H300), and secondary only] and were incubated at 4°C overnight in a humidified chamber. After washing, cells were incubated in the appropriate oligonucleotide-tagged secondary antibodies for 1 hour at 37°C. Cells were washed and enzymatically ligated for 30 minutes at 37°C. Following washes, sperm were incubated for 100 minutes in DNA polymerase at 37°C to induce rolling circle amplification in the presence of fluorescent detection reagents and generate a fluorescent signal at sites of protein interaction. Slides were then washed and counterstained with Yoyo-1 followed by mounting and imaging via confocal microscopy as per the immunofluorescence protocol. At least 150 cells were quantified per treatment, and this experiment was replicated a minimum of 3 times.
Effects of dynamin inhibitors on IVF
Eight-week-old female mice were injected intraperitoneally with 7.5 IU equine chorionic gonadotropin, followed 48 hours later with 7.5 IU human chorionic gonadotropin to promote superovulation. Mice were culled ;14 hours after human chorionic gonadotropin treatment, and ovaries were removed immediately into 37°C PBS. The cumulus mass was retrieved from the ampullae, and oocytes were denuded from cumulus cells via 5-minute incubation in hyaluronidase (300 mg/ml). Oocytes were then washed in M2 media to isolate them from cumulus cells.
In vitro fertilization (IVF) was conducted as previously described (4). Briefly, mouse spermatozoa were divided between the following treatment groups: noncapacitated, capacitated, 6.7 nM CHIR99021 treated, 10 mM Dyngo-4a treated, or DMSO vehicle control treated. A suspension of ;2 3 10 5 cells was then added to fertilization dishes containing oocytes and coincubated for 3-4 hours. Following coincubation, eggs were removed and washed before being cultured overnight at 37°C. Fertilization rates were subsequently determined by counting the number of 2-cell embryos as described previously (4) . Between 20 and 40 oocytes were used for each treatment, and experiments were repeated a minimum of 3 times.
Statistical analysis
All experiments were replicated a minimum of 3 times, with pooled sperm samples obtained from $3 different male mice. Graphical data are presented as mean values 6 SEM, which were calculated from the variance between samples. Statistical significance was determined using an ANOVA.
RESULTS
GSK3 is present in mature mouse spermatozoa
Western blot analysis was used to determine whether the known dynamin I kinases (GSK3 and/or CDK5) are present within mature mouse spermatozoa. Using specific antibodies, we detected 2 predominant bands of ;51 and 47 kDa representing both the a and b isoforms of the GSK3 protein, respectively, within lysates prepared from cauda epididymal spermatozoa, as well as within whole testis tissue lysate (positive control; Fig. 1A) . Notably, there was markedly less GSKb in the sperm protein lysate compared with GSKa. In contrast, GSK3b appeared to be the more abundant isoform in whole testis lysates. The specificity of the anti-GSK3 antibody was demonstrated by abolishing the immunolabeling of both isoforms by preabsorption of the antibody with the immunizing peptide (Fig. 1B) . Although CDK5 was also abundantly expressed in testis lysates, in contrast to GSK3, this kinase was not detectable in protein extracts of cauda epididymal spermatozoa (Fig.  1C) . These data highlight the potential of GSK3 as a candidate for regulating dynamin I Ser-774 phosphorylation in response to progesterone stimulus of mature spermatozoa and does not support any role for CDK5 in dynamin I Ser-778 phosphorylation.
GSK3 localizes to the peri-acrosomal region of the sperm head
The presence of GSK3 was investigated at progressive stages of sperm maturation using immunoblotting and immunofluorescence localization. These studies demonstrated that GSK3 was present in the peri-acrosomal domain, in addition to that of the mid-and principal piece of the tail, in functionally immature caput and proximal corpus epididymal spermatozoa ( Fig. 2A) . Surprisingly, however, the relative levels of immunoreactive GSK3a, but not GSK3b, were significantly higher (P , 0.05) in more functionally mature spermatozoa from the cauda epididymis (Fig. 2B, C) . The elevated level of GSK3a detected by immunoblotting was associated with an approximate doubling of both the intensity of GSK3 immunofluorescence ( Fig. 2A) and the number of spermatozoa displaying labeling within the peri-acrosomal domain ( Fig. 2D and Supplemental Fig. S2 ) between the caput and cauda epididymis. This increase in immunoreactive GSK3 was unexpected because haploid spermatozoa are transcriptionally and translationally silent: it is therefore possible that such changes reflect unmasking or de novo acquisition of Figure 1 . GSK3 is present in mature mouse spermatozoa. Cell lysates prepared by SDS extraction of cauda epididymal mouse spermatozoa (20 mg) and testis homogenates (10 mg) were immunoblotted with antibodies directed against GSK3 or CDK5. A) Two bands were detected at the correct molecular mass for GSK3, representing the GSK3a and GSK3b isoforms, within both samples, although spermatozoa displayed considerably more of the larger GSK3a isoform. B) The specificity of these bands was demonstrated by the absence of labeling in sperm lysates following preabsorption of the anti-GSK3 antibodies with the immunizing peptide (IP) against which they were raised (+IP). However, the bands were readily able to be detected once this membrane was stripped and reprobed with nonabsorbed antibody (2IP). C) A single band corresponding to CDK5 was detected within testis lysate, whereas there was no equivalent band within spermatozoa. These experiments were repeated 3 times using pooled sperm and testis samples from $3 mice, and representative immunoblots are shown.
this protein (see below). Notwithstanding such changes, the localization of GSK3 was not overtly influenced by the capacitation status of the cells or by progesterone challenge (data not shown). The presence of GSK3 within the peri-acrosomal domain is consistent with that previously reported for dynamin I and II (4). Preabsorption of anti-GSK3 with immunizing peptide eliminated all sperm labeling (Fig. 2B) . In contrast to GSK3, CDK5 staining was not detected within epididymal spermatozoa irrespective of their maturational status (data not shown). Thus, in support of the Western blot data, GSK3 but not CDK5 is localized to a region of the mature sperm head compatible with a role in targeting dynamin.
GSK3 and dynamin I colocalize within the sperm head
To determine whether GSK3 is appropriately positioned to mediate dynamin I Ser-774 phosphorylation, we used a PLA (33, 34) . This assay determines whether 2 proteins reside within a maximum distance of 30-40 nm of each other by ligating 2 distinct oligonucleotides tagged to species-specific secondary antibodies. Very few noncapacitated spermatozoa produced positive PLA fluorescent signals, indicating that GSK3 and dynamin I were not closely opposed within these cells (Fig. 3A, B) . However, 25-30% of capacitated spermatozoa and those treated with progesterone displayed numerous foci of red fluorescence across the peri-acrosomal region of the sperm head (Fig.  3A, B) . The modest decline in the number of spermatozoa exhibiting this staining pattern in the progesterone-treated sample compared with capacitated spermatozoa (P . 0.05) is most likely attributed to increased acrosomal exocytosis in the former population. Therefore, GSK3 and dynamin I are repositioned to within a maximum of 30-40 nm of each other during capacitation and remain in close proximity following treatment with progesterone.
The specificity of this assay was confirmed through the inclusion of a number of negative controls (Fig. 3B, C) . These included antibodies against ACRBP, which localizes to the acrosomal matrix of mouse spermatozoa, and HSPD1, which resides in an intracellular location before being expressed on the outer leaflet of the capacitated sperm plasma membrane (27, 35) . Despite this, ,5% of progesterone-treated spermatozoa generated red fluorescence when tested for proximity of either ACRBP or HSPD1 and GSK3; thus, these proteins do not form close associations within these cells, unlike the GSK3/dynamin I protein couple.
GSK3 localizes to epididymal dense bodies
Because spermatozoa are incapable of de novo gene transcription and protein translation, we next aimed to determine whether additional GSK3 is acquired by these cells during epididymal transport by examining the localization of this protein in different segments of the mouse epididymis. The observations confirmed an apparent increase in GSK3 labeling in both the epididymal lumen and surrounding epithelium in the corpus and caudal regions (Fig. 4A) . The luminal labeling included both spermatozoa Figure 2 . Detection and immunofluorescent localization of GSK3 in mouse spermatozoa. A) Epididymal spermatozoa (caput, corpus, cauda) were incubated with antibodies against GSK3 to determine the localization of the kinase (red). Following immunolabeling, the cells were counterstained with the FITCconjugated PNA (green), a marker of the outer acrosomal membrane. GSK3 colocalized with PNA in the peri-acrosomal region of all cells types; however, there was an approximate doubling in the intensity of staining and (D) the percentage of cells exhibiting peri-acrosomal labeling in cauda spermatozoa. A) This positive staining was abolished following preabsorption of anti-GSK3 antibodies with immunizing peptide (+IP), again highlighting the selectivity of the anti-GSK3 antibody. B) Increases in GSK3 immunoreactivity were also assessed in SDS cell lysates (20 mg) of purified populations of epididymal spermatozoa (caput, corpus, cauda). Both GSK3a and GSK3b isoforms were detected in epididymal spermatozoa (arrowheads). However, the larger GSK3a isoform was the predominant isoform represented in these cells. C) Densitometric analysis was performed on proteins bands corresponding to GSK3a and GSK3b to determine their labeling intensities relative to that of an a-tubulin loading control (not shown). These data revealed a significant increase in GSK3a, but not GSK3b, labeling between the caput and cauda samples. These experiments were repeated 5 times, and representative images are shown. Quantitative data are represented as means 6 SEM. *P , 0.05 compared with caput sample. Scale bar, 10 mm. and a population of intensely stained amorphous, granulelike extracellular structures. Such structures were labeled in all epididymal regions downstream of the proximal corpus (Fig. 4A ) and appeared to correspond to nonmembrane-bound entities known as epididymal dense bodies that have previously been reported within the lumen of the mouse epididymis (27) . Control incubations in which the GSK3 antibody was preabsorbed with the immunizing peptide did not generate a positive signal (Fig.  4B) . The GSK3 staining of these extracellular protein aggregates in therefore specific and may represent a mechanism for effecting the bulk transfer of GSK3 to spermatozoa maturing within the epididymal lumen (27) .
To confirm that GSK3 did indeed reside within dense bodies, epididymal sections were dual-labeled with combinations of anti-GSK3, anti-HSPD1, and anti-BPI antibodies, the latter being established markers of the dense body population (27, 36) . All proteins strongly colocalized within the majority of dense bodies (Fig. 4C, D) . This was confirmed by immunogold ultrastructural analyses whereby gold-labeled GSK3 proteins were detected within dense bodies in the corpus region of the epididymis (Fig.  5A, arrowheads) . These ultrastructural analyses also revealed that some dense bodies directly interact with spermatozoa ( Fig. 5B ) with their contents, including goldlabeled GSK3 proteins (Fig. 5C, arrowheads) , appearing to extend out over the cell surface. Importantly, no labeling of dense bodies or spermatozoa was detected in controls using only secondary antibody (Supplemental Fig. S3 ) or in sections incubated with anti-GSK3 antibodies that had previously been preabsorbed with immunizing peptide (Fig. 5D ). These observations raise the possibility that an additional pool of GSK3 may be acquired by maturing spermatozoa from the dense bodies as these cells traverse the epididymis.
Inhibition of GSK3 reduces the progesterone-induced acrosome reaction
The demonstration that GSK3 colocalizes with dynamin in the peri-acrosomal region of mature spermatozoa suggests that the kinase may be involved in the regulation of acrosomal exocytosis. To test this, we used 3 cell-permeable highly selective GSK3 inhibitors: CHIR99021 (IC 50 6.7 nM GSK3b; 10 nM GSK3a); A1070722 (Ki 0.6 nM; both isoforms), and TWS-119 (IC 50 30 nM GSK3b) (28) (29) (30) (31) . Spermatozoa were incubated with these inhibitors (CHIR99021: 1, 6.7, 67 nM; A1070722: 0.6, 6, 60 nM; TWS-119: 0.3, 3, 30 mM), as well as 0.02% DMSO (vehicle control) during capacitation and were subsequently challenged with 15 mM progesterone. At the inhibitor concentrations selected, no detrimental impact on sperm motility or vitality was noted, both of which remained .80% in all treatments (Fig. 6A) . Progesterone produced the expected increase in the number of acrosome reactions (;20%) between the noncapacitated and capacitated (DMSO) control populations of spermatozoa (Fig.  6B-D) . The GSK3 inhibitor CHIR99021 elicited a dosedependent decrease in the number of spermatozoa that had undergone the progesterone-induced acrosome reaction (Fig. 6B) . At 6.7 nM, CHIR99021 significantly reduced (P , 0.05) the percentage of acrosome reacted cells to approximately one third the levels observed in the DMSO controls, whereas at 103 this concentration, the level of acrosomal exocytosis approximated that of the noncapacitated sample and that observed in the presence of the dynamin inhibitor Dyngo-4a (4) (Fig. 6B) . Similar concentration-dependent reductions in acrosomal exocytosis were observed after treatment with increasing concentrations of A1070722 (Fig. 6C ) and TWS-119 (Fig. 6D) , although the latter was only effective at concentrations Figure 3 . Analysis of fluorescence resulting from PLAs. Noncapacitated, capacitated, or capacitated + progesterone-treated spermatozoa were subjected to PLA to detect the colocalization of GSK3 with dynamin I (GSK3: dynI). Cells were also counterstained with the DNA marker Yoyo-1 (green). Negative controls included pairs of antibodies against GSK3:ACRBP and GSK3:HSPD1 in addition to a minus primary. A) Noncapacitated spermatozoa failed to exhibit positive PLA signals (red fluorescence) with any of the antibody combinations. B) In contrast, a large number of capacitated and progesterone-treated spermatozoa exhibited positive PLA signals for GSK3:dynI within the sperm head, indicative of the proteins being in close enough proximity for kinase/substrate interactions. C) Few spermatozoa in the negative controls exhibited red PLA fluorescence. Representative images are shown for each treatment, and each experiment was replicated 3 times, with quantitative data represented as means 6 SEM. *P , 0.05, ** P , 0.01. Scale bar, 5 mm.
well above that of its reported IC 50 value. In addition to regulation of the pathway leading to acrosomal exocytosis, GSK3 inhibition also had a notable effect on IVF rates. Thus, preincubation of sperm with CHIR99021 led to a highly significant reduction in fertilization rate as measured by the production of 2-cell embryos (Fig. 6E) . In contrast, a selective cyclin-dependent kinase inhibitor (roscovitine) that targets CDK1, CDK2, and CDK5 with similar potency failed to elicit any reduction in acrosomal exocytosis or IVF rates (data not shown).
Inhibition of GSK3 prevents dynamin phosphorylation in vitro
In view of the close association of GSK3 and dynamin in mature spermatozoa and the demonstration that both contribute to the regulation of acrosomal exocytosis, we next sought to examine the causal nature of this association by determining whether GSK3 is capable of targeting the specific phosphorylation of dynamin Ser-774 as reported in other excitable cell types (8) . Dynamin phosphorylation was assessed by immunofluorescence (Supplemental Fig. S1 ) using validated phospho-specific antibodies (4), following treatment of spermatozoa with GSK3 inhibitors. Each GSK3 inhibitor induced a concentrationdependent reduction in Ser-774 phosphorylation (Fig.  7) . In the case of both CHIR99021 and A1070722, significant inhibition of Ser-774 phosphorylation was achieved at the published IC 50 values of these inhibitors. However, TWS-119 was only effective at reducing Ser-774 phosphorylation at concentrations ;100-fold greater than its IC 50 value (Fig. 7C, D) . Figure 4 . Detection of GSK3 within mouse epididymis. A) Tissue sections were subjected to immunolocalization with antibodies against GSK3 (green) and counterstained with the nuclear dye propidium iodide (red). There was minimal labeling of GSK3 in spermatozoa and epithelial cells within the caput epididymis. In contrast, GSK3 was readily detected in the epididymal epithelium in the corpus and caudal regions of the duct (arrows). GSK3 was also strongly localized within dense body structures immediately adjacent to spermatozoa within the lumen of the corpus and cauda epididymis (arrowheads). B) The selectivity of the anti-GSK3 antibody labeling was demonstrated by preabsorption with (+IP) and without (2IP) immunizing peptide. C, D) Dual immunofluorescent labeling confirmed strong colocalization of GSK3 (green), (C) the molecular chaperone HSPD1 (red), and (D) BPI (red) within dense bodies in sections of epididymal tissue. Scale bars, 40 mm.
DISCUSSION
Our study reveals 3 key observations concerning the mammalian sperm acrosome reaction. First, we showed that GSK3 colocalizes with dynamin in the peri-acrosomal region of the sperm head and is the protein kinase responsible for dynamin phosphorylation, largely ruling out a role for CDK5. Second, we generated data indicating that GSK3 is critically involved in the mediation of acrosomal exocytosis and fertilization. Third, we found that, although low levels of GSK3 are present in immature spermatozoa, additional protein is acquired late in maturation, and this might occur by a novel mechanism of transfer into spermatozoa from discrete extracellular proteinaceous accretions known as epididymal dense bodies.
Consistent with previous evidence that spermatozoa present enzyme profiles that are distinct from those present in somatic tissues (37, 38) , we demonstrated that CDK5 is absent in mature mouse spermatozoa and that a broad spectrum CDK inhibitor had no effect on acrosomal exocytosis. Although GSK3 was detected within these cells, the 2 ubiquitously expressed somatic homologs, GSK3a and GSK3b (39), were not equally represented, with substantially more GSKa being detected in mature spermatozoa. Despite these differences, our novel application of proximity ligation assays enabled visualization of a putative kinase/substrate interaction between GSK3 and dynamin in the peri-acrosomal region of mouse spermatozoa. This interaction appeared to be driven via subtle repositioning of the protein(s) following the functional priming of the cell during capacitation and culminated in the phosphorylation of dynamin I at Ser-774. Pharmacological inhibition studies confirmed the importance of this interaction, with the suppression of GSK3 activity resulting in a concomitant reduction in the ability of spermatozoa to complete an acrosome reaction in response to progesterone challenge and to fertilize an oocyte.
An important observation from our combined immunoblotting and immunofluorescent studies was that the relative amount of immunoreactive GSK3 present within the peri-acrosomal region of spermatozoa appears to increase as spermatozoa move through the epididymis. Although we cannot rule out the importance of constitutively expressed GSK3, this maturational profile mirrors the acquired ability of spermatozoa to engage in acrosomal exocytosis during epididymal transit (40) , thus raising the possibility that additional GSK3 is acquired during sperm maturation to regulate signaling pathways that underpin this critical aspect of sperm function. Consistent with this notion, GSK3 appears to be synthesized and secreted by the mouse epididymis and is concentrated in epididymal luminal structures, corresponding to previously described proteinaceous accretions known as epididymal dense bodies (27) . Epididymal dense bodies were proposed to participate in the functional remodeling of spermatozoa during maturation by mediating the bulk transfer of proteins to these cells within the epididymal lumen (27, 41) . To date no proteomic analysis of epididymal dense bodies has been undertaken; however, epididymal aggregates of similar structure have been shown to contain molecular chaperones (HSPD1, HSPE1, and HSP90B1) in addition to carbohydrate-rich aggregates that promote the formation of sperm rosettes (42) and the bactericidal permeability-increasing protein that also becomes distributed over the acrosomal region of the sperm head during epididymal transit (43) .
Although we cannot discount the possibility that the additional GSK3 is acquired by other means, immunogold labeling of GSK3 in mouse epididymal sections offered strong support for the presence of the kinase within dense bodies and also provided insight into potential mechanisms governing the extracellular trafficking of this protein to spermatozoa (27) . Indeed, physical interactions are formed between some epididymal dense bodies and spermatozoa, and it is possible these may facilitate the transfer Figure 5 . Immunogold labeling of GSK3 within the mouse epididymis. Electron microscopy was used with immunogold labeling to investigate the localization of GSK3 within the corpus (A) and cauda (B, C) epididymis. A) A representative dense body (DB) present within the corpus epididymis as viewed under electron microscopy exhibiting positive labeling for GSK3 (white arrowheads). B) Association of dense bodies with spermatozoa within the lumen (L) of the cauda epididymis and (C) higher magnification of B demonstrating the association and potential transfer of GSK3 (black arrowheads) from the dense body to the acrosomal (Acr) region of the spermatozoon. D) The specificity of immunogold labeling was confirmed through the inclusion of a secondary antibody only control. N, nucleus. Scale bars, 0.2 mm.
of signaling proteins such as GSK3 to spermatozoa during epididymal maturation. Although the mechanisms governing docking, transport, and internalization of dense body cargo remain to be identified, a number of studies offer important precedents for these findings. It is well documented that, as transcriptionally and translationally silent cells, spermatozoa are reliant on the acquisition of novel proteins that are secreted from the epididymal epithelium (44) (45) (46) (47) . These proteins include key signaling molecules such as the tyrosine kinase cSrc (48) and phosphatidylethanolamine binding protein 1 (49) , an inhibitor of the Raf/MEK/ERK pathway, both of which play important roles in the regulation of capacitation (23, 50) . A recent comprehensive analysis of the proteomic composition of the mouse sperm acrosome has revealed that it undergoes substantial changes between the caput and cauda regions of the epididymis (51) . Specifically, a large number of proteins encompassing an impressive range of functional categories, including proteases, hydrolases, transporters, enzyme modulators, chaperones, transferases, and cytoskeletal proteins, are targeted to the acrosomal matrix during epididymal maturation (51) . Taken together, these observations suggest that the process of epididymal sperm maturation extends beyond the widely studied surface remodeling events to include the acquisition of intracellular signaling systems necessary for the regulation of sperm fertilizing ability. Such observations may, in part, account for why mouse spermatozoa cannot be induced to acrosome react before completing their transit of the proximal corpus epididymis (40) . This notion is supported by our data indicating that epididymal sperm recovered upstream of the distal corpus region were unable to respond to progesterone stimulus through the phosphorylation of dynamin I Ser-774.
In conclusion, GSK3 has been identified as a critical kinase in the progesterone-induced acrosome reaction that mediates the phosphorylation of dynamin I at Ser-774. We hypothesize that this is a crucial step in the progression of the acrosome reaction in mouse spermatozoa, leading to decreased activity of dynamin and a putative stabilization of the plasma membrane fusion pores. Our data also provide the first ultrastructural evidence to suggest that GSK3 may be acquired by maturing spermatozoa from epididymal dense bodies. Collectively, these results afford novel Figure 6 . Investigation into the effect of pharmacological inhibition of GSK3 on the progesterone-induced acrosome reaction in mouse spermatozoa. Sperm were either noncapacitated (Non-Cap), capacitated in the presence of specific inhibitors of GSK3 (CHIR99021, A1070722, or TWS-119), or capacitated + 0.02% DMSO vehicle (DMSO), followed by progesterone treatment. Dyngo-4a (100 mM) was used as positive control. CHIR99021 was used at 1, 6.7, or 67 nM; A1070722 at 0.6, 6, or 60 nM; TWS-119 at 0.3, 3, or 30 mM. Viable cells were detected through the use of a hypoosmotic swelling assay and recorded as acrosome reacted on the loss of PNA staining. A) Importantly, none of these treatments has any notable effect on sperm motility or viability, both of which remained .80%. However, inhibition of GSK3 with (B) CHIR99021, (C) A1070722, and (D) TWS-119 lead to a significant dose-dependent decrease in the number of viable sperm undergoing the acrosome reaction. Dyngo-4a reduced the frequency of acrosome reactions to near noncapacitated levels. Each experiment was replicated $3 times, and the results are presented as the means 6 SEM. *P , 0.05, **P , 0.01, ***P , 0.001. E) In addition to reducing acrosome reaction rates, CHIR99021 also proved effective at inhibiting fertilization in vitro as determined by the number of 2-cell embryos generated following incubation of spermatozoa in CHIR99021. Normalization of these data to DMSO control values demonstrated a significant reduction in the fertilization rate of the GSK3-inhibited sample. This experiment was replicated 3 times, and the results are presented as the means 6 SEM. **P , 0.01, ***P , 0.001.
insights into the intricacy of the sperm maturation process whereby the immature spermatozoa that leave the testes are progressively remodeled so that they gain the potential to complete the acrosome reaction and fertilize an oocyte. Furthermore, GSK3 is unusual among kinases in that it usually requires a priming kinase to first phosphorylate a substrate. A phosphorylated serine or threonine residue located 4 amino acids C-terminal to the target site of phosphorylation allows the substrate to bind a pocket of positive charge formed by arginine and lysine residues (52, 53) . Our future work will focus on the identification of the priming kinase responsible for phosphorylation of dynamin Ser-778 in addition to determination of the mechanisms that target the protein cargo of dense bodies to maturing spermatozoa. Figure 7 . Impact of GSK3 inhibition on dynamin phosphorylation. Coimmunolabeling of dynI-p774 and the outer acrosomal membrane marker PNA was conducted in the following populations of progesterone-challenged spermatozoa: noncapacitated (Non-Cap), capacitated + DMSO (DMSO), and GSK3 inhibited (CHIR99021, A 1070722 or TWS-119). Spermatozoa exhibiting peri-acrosomal labeling for dynI-p774 were quantified as described in the Materials and Methods. These data revealed that GSK3 inhibition with (A) CHIR99021, (B) A1070722, or (C) TWS-119 leads to significant reductions in the progesterone-induced phosphorylation of dynamin I serine 774 within the peri-acrosomal region of mature spermatozoa. D) A Western blot is included to confirm the specificity of the phospho-dynamin antibodies (dynI-p774) used for this study. These antibodies labeled a predominant band corresponding to the predicted molecular weight of dynamin I (arrowhead). As anticipated, the labeling of this band was abolished by pretreatment of the sperm lysate with Antarctic phosphatase (+AP). Following labeling, the blots were stripped and reprobed with antitubulin antibodies to confirm equal protein loading. Representative images are shown for each treatment. Each experiment was replicated 3 times, and the results are presented as the means 6 SEM. *P , 0.05, **P , 0.01, ***P , 0.001. 
